Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 620

1.

A pilot study of naltrexone-accelerated detoxification in opioid dependence.

Bell JR, Young MR, Masterman SC, Morris A, Mattick RP, Bammer G.

Med J Aust. 1999 Jul 5;171(1):26-30.

PMID:
10451668
3.

Naltrexone shortened opioid detoxification with buprenorphine.

Umbricht A, Montoya ID, Hoover DR, Demuth KL, Chiang CT, Preston KL.

Drug Alcohol Depend. 1999 Oct 1;56(3):181-90.

PMID:
10529020
5.

Naltrexone-assisted rapid methadone discontinuation: a pilot study.

Camarasa X, Khazaal Y, Besson J, Zullino DF.

Eur Addict Res. 2007;13(1):20-4.

PMID:
17172775
6.

Comparing drug-related hospital morbidity following heroin dependence treatment with methadone maintenance or naltrexone implantation.

Ngo HT, Tait RJ, Hulse GK.

Arch Gen Psychiatry. 2008 Apr;65(4):457-65. doi: 10.1001/archpsyc.65.4.457.

PMID:
18391134
7.

Ultra-rapid opiate detoxification using deep sedation and prior oral buprenorphine preparation: long-term results.

Bochud Tornay C, Favrat B, Monnat M, Daeppen JB, Schnyder C, Bertschy G, Besson J.

Drug Alcohol Depend. 2003 Apr 1;69(3):283-8.

PMID:
12633914
8.

Anesthesia-assisted vs buprenorphine- or clonidine-assisted heroin detoxification and naltrexone induction: a randomized trial.

Collins ED, Kleber HD, Whittington RA, Heitler NE.

JAMA. 2005 Aug 24;294(8):903-13.

PMID:
16118380
9.

Rapid opiate detoxication in outpatient treatment: relationship with naltrexone compliance.

Gerra G, Zaimovic A, Rustichelli P, Fontanesi B, Zambelli U, Timpano M, Bocchi C, Delsignore R.

J Subst Abuse Treat. 2000 Mar;18(2):185-91.

PMID:
10716102
10.
11.

24-Hour opiate detoxification and antagonist induction at home--the 'Asturian method': a report on 1368 procedures.

Carreño JE, Bobes J, Brewer C, Alvarez CE, San Narciso GI, Bascarán MT, Sánchez del Río J.

Addict Biol. 2002 Apr;7(2):243-50.

PMID:
12006220
12.

Does naltrexone affect craving in abstinent opioid-dependent patients?

Dijkstra BA, De Jong CA, Bluschke SM, Krabbe PF, van der Staak CP.

Addict Biol. 2007 Jun;12(2):176-82.

PMID:
17508990
13.

An open-label study of a functional opioid kappa antagonist in the treatment of opioid dependence.

Rothman RB, Gorelick DA, Heishman SJ, Eichmiller PR, Hill BH, Norbeck J, Liberto JG.

J Subst Abuse Treat. 2000 Apr;18(3):277-81.

PMID:
10742642
14.
15.

Short-term outcomes of five heroin detoxification methods in the Australian NEPOD Project.

Digiusto E, Lintzeris N, Breen C, Kimber J, Mattick RP, Bell J, Ali R, Saunders JB; NEPOD Research Group.

Addict Behav. 2005 Mar;30(3):443-56.

PMID:
15718062
16.

Opioid detoxification with buprenorphine, clonidine, or methadone in hospitalized heroin-dependent patients with HIV infection.

Umbricht A, Hoover DR, Tucker MJ, Leslie JM, Chaisson RE, Preston KL.

Drug Alcohol Depend. 2003 Apr 1;69(3):263-72.

PMID:
12633912
17.

Mortality in heroin users 3 years after naltrexone implant or methadone maintenance treatment.

Tait RJ, Ngo HT, Hulse GK.

J Subst Abuse Treat. 2008 Sep;35(2):116-24. Epub 2007 Oct 10.

PMID:
17931824
18.

[Detoxification in withdrawal state in methadone maintenance patients].

Sivolap I, Savchenkov VA, Aksel'rod BA, Kubarev DA, Chichenkov TO.

Zh Nevrol Psikhiatr Im S S Korsakova. 2003;103(11):33-7. Russian.

PMID:
14681963
19.

Serendipitous rapid detoxification from opiates: the importance of time-dependent processes.

Mannelli P, De Risio S, Pozzi G, Janiri L, De Giacomo M.

Addiction. 1999 Apr;94(4):589-91.

PMID:
10605854
20.

Rapid detoxification from opioid dependence under general anaesthesia versus standard methadone tapering: abstinence rates and withdrawal distress experiences.

Krabbe PF, Koning JP, Heinen N, Laheij RJ, van Cauter RM, De Jong CA.

Addict Biol. 2003 Sep;8(3):351-8.

PMID:
13129838

Supplemental Content

Support Center